Role of immunolglobulin-like transcript family receptors and their ligands in suppressor T-cell-induced dendritic cell tolerization

Human Immunology

Volumn 70, Issue 9, 2009, Pages 686-691

  Chui, Cecilia S C ^a   Li, Demin ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

CD1d; DC tolerization; ILT family; MHC I; Suppressor T cells

Indexed keywords

CD1D ANTIGEN; HLA B27 ANTIGEN; HLA G ANTIGEN; IMMUNOGLOBULIN LIKE TRANSCRIPT 3 PROTEIN; IMMUNOGLOBULIN LIKE TRANSCRIPT 4 PROTEIN; IMMUNOGLOBULIN LIKE TRANSCRIPT PROTEIN; LYMPHOCYTE MEMBRANE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL STIMULATION; CELLULAR IMMUNITY; CRYSTAL STRUCTURE; DENDRITIC CELL; HOST RESISTANCE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; LIGAND BINDING; LYMPHOCYTE PROLIFERATION; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS; ANTIGENS, CD1; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; MEMBRANE GLYCOPROTEINS; MULTIPROTEIN COMPLEXES; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES, REGULATORY;

EID: 68749114977     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.06.003     Document Type: Review

References (77)

1. Kyewski B., and Klein L. A central role for central tolerance. Annu Rev Immunol 24 (2006) 571-606
2. Gallegos A.M., and Bevan M.J. Central tolerance: Good but imperfect. Immunol Rev 209 (2006) 290-296
3. Redmond W.L., and Sherman L.A. Peripheral tolerance of CD8 T lymphocytes. Immunity 22 (2005) 275-284
4. Hoyne G.F., Dallman M.J., and Lamb J.R. T-cell regulation of peripheral tolerance and immunity: The potential role for Notch signaling. Immunology 100 (2000) 281-288
5. Vignali D.A., Collison L.W., and Workman C.J. How regulatory T cells work. Nat Rev Immunol 8 (2008) 523-532
6. Sakaguchi S., Sakaguchi N., Shimizu J., Yamazaki S., Sakihama T., Itoh M., et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: Their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 182 (2001) 18-32
7. Shevach E.M., DiPaolo R.A., Andersson J., Zhao D.M., Stephens G.L., and Thornton A.M. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol Rev 212 (2006) 60-73
8. Collison L.W., Workman C.J., Kuo T.T., Boyd K., Wang Y., Vignali K.M., et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450 (2007) 566-569
9. Grossman W.J., Verbsky J.W., Tollefsen B.L., Kemper C., Atkinson J.P., and Ley T.J. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 104 (2004) 2840-2848
10. Gondek D.C., Lu L.F., Quezada S.A., Sakaguchi S., and Noelle R.J. Cutting edge: Contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 174 (2005) 1783-1786
11. Liu Z., Tugulea S., Cortesini R., and Suciu-Foca N. Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28- T cells. Int Immunol 10 (1998) 775-783
12. Suciu-Foca N., Manavalan J.S., Scotto L., Kim-Schulze S., Galluzzo S., Naiyer A.J., et al. Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: Review. Int Immunopharmacol 5 (2005) 7-11
13. Manavalan J.S., Kim-Schulze S., Scotto L., Naiyer A.J., Vlad G., Colombo P.C., et al. Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 16 (2004) 1055-1068
14. Scotto L., Naiyer A.J., Galluzzo S., Rossi P., Manavalan J.S., Kim-Schulze S., et al. Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells. Hum Immunol 65 (2004) 1297-1306
15. Vlad G., Cortesini R., and Suciu-Foca N. CD8+ T suppressor cells and the ILT3 master switch. Hum Immunol 69 (2008) 681-686
16. Suciu-Foca N., and Cortesini R. Central role of ILT3 in the T suppressor cell cascade. Cell Immunol 248 (2007) 59-67
17. Li D., Wang L., Yu L., Freundt E.C., Jin B., Screaton G.R., et al. Ig-like transcript 4 inhibits lipid antigen presentation through direct CD1d interaction. J Immunol 182 (2009) 1033-1040
18. Lichterfeld M., Kavanagh D.G., Williams K.L., Moza B., Mui S.K., Miura T., et al. A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cells. J Exp Med 204 (2007) 2813-2824
19. Colonna M., Nakajima H., and Cella M. A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cells. Semin Immunol 12 (2000) 121-127
20. Brown D., Trowsdale J., and Allen R. The LILR family: Modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 64 (2004) 215-225
21. Barrow A.D., and Trowsdale J. The extended human leukocyte receptor complex: Diverse ways of modulating immune responses. Immunol Rev 224 (2008) 98-123
22. Isakov N. ITIMs and ITAMs. The yin and yang of antigen and Fc receptor-linked signaling machinery. Immunol Res 16 (1997) 85-100
23. Colonna M., Navarro F., Bellon T., Llano M., Garcia P., Samaridis J., et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186 (1997) 1809-1818
24. Colonna M., Samaridis J., Cella M., Angman L., Allen R.L., O'Callaghan C.A., et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 160 (1998) 3096-3100
25. Cella M., Dohring C., Samaridis J., Dessing M., Brockhaus M., Lanzavecchia A., et al. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med 185 (1997) 1743-1751
26. Colonna M., Nakajima H., Navarro F., and Lopez-Botet M. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J Leukoc Biol 66 (1999) 375-381
27. Fanger N.A., Cosman D., Peterson L., Braddy S.C., Maliszewski C.R., and Borges L. The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur J Immunol 28 (1998) 3423-3434
28. Nakajima H., Samaridis J., Angman L., and Colonna M. Human myeloid cells express an activating ILT receptor (ILT1) that associates with Fc receptor gamma-chain. J Immunol 162 (1999) 5-8
29. Cao W., Rosen D.B., Ito T., Bover L., Bao M., Watanabe G., et al. Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J Exp Med 203 (2006) 1399-1405
30. Borges L., Hsu M.L., Fanger N., Kubin M., and Cosman D. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol 159 (1997) 5192-5196
31. Cosman D., Fanger N., Borges L., Kubin M., Chin W., Peterson L., et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7 (1997) 273-282
32. Navarro F., Llano M., Bellon T., Colonna M., Geraghty D.E., and Lopez-Botet M. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol 29 (1999) 277-283
33. Lepin E.J., Bastin J.M., Allan D.S., Roncador G., Braud V.M., Mason D.Y., et al. Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors. Eur J Immunol 30 (2000) 3552-3561
34. Allan D.S., Lepin E.J., Braud V.M., O'Callaghan C.A., and McMichael A.J. Tetrameric complexes of HLA-E, HLA-F, and HLA-G. J Immunol Methods 268 (2002) 43-50
35. Hayami K., Fukuta D., Nishikawa Y., Yamashita Y., Inui M., Ohyama Y., et al. Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors. J Biol Chem 272 (1997) 7320-7327
36. Kubagawa H., Burrows P.D., and Cooper M.D. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc Natl Acad Sci U S A 94 (1997) 5261-5266
37. Yamashita Y., Fukuta D., Tsuji A., Nagabukuro A., Matsuda Y., Nishikawa Y., et al. Genomic structures and chromosomal location of p91, a novel murine regulatory receptor family. J Biochem 123 (1998) 358-368
38. Takai T. A novel recognition system for MHC class I molecules constituted by PIR. Adv Immunol 88 (2005) 161-192
39. Kollnberger S., Bird L.A., Roddis M., Hacquard-Bouder C., Kubagawa H., Bodmer H.C., et al. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors. J Immunol 173 (2004) 1699-1710
40. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu Rev Immunol 21 (2003) 685-711
41. Yamazaki S., Iyoda T., Tarbell K., Olson K., Velinzon K., Inaba K., et al. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med 198 (2003) 235-247
42. Woltman A.M., and van Kooten C. Functional modulation of dendritic cells to suppress adaptive immune responses. J Leukoc Biol 73 (2003) 428-441
43. Lutz M.B., and Schuler G. Immature, semi-mature and fully mature dendritic cells: Which signals induce tolerance or immunity?. Trends Immunol 23 (2002) 445-449
44. Piersma S.J., Welters M.J., and van der Burg S.H. Tumor-specific regulatory T cells in cancer patients. Hum Immunol 69 (2008) 241-249
45. Chang C.C., Ciubotariu R., Manavalan J.S., Yuan J., Colovai A.I., Piazza F., et al. Tolerization of dendritic cells by T(S) cells: The crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 3 (2002) 237-243
46. Manavalan J.S., Rossi P.C., Vlad G., Piazza F., Yarilina A., Cortesini R., et al. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl Immunol 11 (2003) 245-258
47. Ristich V., Liang S., Zhang W., Wu J., and Horuzsko A. Tolerization of dendritic cells by HLA-G. Eur J Immunol 35 (2005) 1133-1142
48. Young N.T., Waller E.C., Patel R., Roghanian A., Austyn J.M., and Trowsdale J. The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells. Blood 111 (2008) 3090-3096
49. Nakamura A., Kobayashi E., and Takai T. Exacerbated graft-versus-host disease in Pirb-/- mice. Nat Immunol 5 (2004) 623-629
50. Ujike A., Takeda K., Nakamura A., Ebihara S., Akiyama K., and Takai T. Impaired dendritic cell maturation and increased T(H)2 responses in PIR-B(-/-) mice. Nat Immunol 3 (2002) 542-548
51. Liang S., Baibakov B., and Horuzsko A. HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. Eur J Immunol 32 (2002) 2418-2426
52. Vlad G., Liu Z., Zhang Q.Y., Cortesini R., and Suciu-Foca N. Immunosuppressive activity of recombinant ILT3. Int Immunopharmacol 6 (2006) 1889-1894
53. Vlad G., D'Agati V.D., Zhang Q.Y., Liu Z., Ho E.K., Mohanakumar T., et al. Immunoglobulin-like transcript 3-Fc suppresses T-cell responses to allogeneic human islet transplants in hu-NOD/SCID mice. Diabetes 57 (2008) 1878-1886
54. Kim-Schulze S., Scotto L., Vlad G., Piazza F., Lin H., Liu Z., et al. Recombinant Ig-like transcript 3-Fc modulates T cell responses via induction of Th anergy and differentiation of CD8+ T suppressor cells. J Immunol 176 (2006) 2790-2798
55. Beinhauer B.G., McBride J.M., Graf P., Pursch E., Bongers M., Rogy M., et al. Interleukin 10 regulates cell surface and soluble LIR-2 (CD85d) expression on dendritic cells resulting in T cell hyporesponsiveness in vitro. Eur J Immunol 34 (2004) 74-80
56. Kuroki K., and Maenaka K. Immune modulation of HLA-G dimer in maternal-fetal interface. Eur J Immunol 37 (2007) 1727-1729
57. Le Bouteiller P., and Blaschitz A. The functionality of HLA-G is emerging. Immunol Rev 167 (1999) 233-244
58. McIntire R.H., and Hunt J.S. Antigen presenting cells and HLA-G-a review. Placenta 26 Suppl A (2005) S104-S109
59. Hunt J.S., Petroff M.G., McIntire R.H., and Ober C. HLA-G and immune tolerance in pregnancy. FASEB J 19 (2005) 681-693
60. Ristich V., Zhang W., Liang S., and Horuzsko A. Mechanisms of prolongation of allograft survival by HLA-G/ILT4-modified dendritic cells. Hum Immunol 68 (2007) 264-271
61. Shiroishi M., Kuroki K., Rasubala L., Tsumoto K., Kumagai I., Kurimoto E., et al. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc Natl Acad Sci USA 103 (2006) 16412-16417
62. Willcox B.E., Thomas L.M., and Bjorkman P.J. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat Immunol 4 (2003) 913-919
63. Shiroishi M., Kuroki K., Tsumoto K., Yokota A., Sasaki T., Amano K., et al. Entropically driven MHC class I recognition by human inhibitory receptor leukocyte Ig-like receptor B1 (LILRB1/ILT2/CD85j). J Mol Biol 355 (2006) 237-248
64. Liang S., Zhang W., and Horuzsko A. Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function. Eur J Immunol 36 (2006) 2457-2471
65. Endo S., Sakamoto Y., Kobayashi E., Nakamura A., and Takai T. Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells. Proc Natl Acad Sci USA 105 (2008) 14515-14520
66. Masuda A., Nakamura A., Maeda T., Sakamoto Y., and Takai T. Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation. J Exp Med 204 (2007) 907-920
67. Hava D.L., Brigl M., van den Elzen P., Zajonc D.M., Wilson I.A., and Brenner M.B. CD1 assembly and the formation of CD1-antigen complexes. Curr Opin Immunol 17 (2005) 88-94
68. Zeng Z., Castano A.R., Segelke B.W., Stura E.A., Peterson P.A., and Wilson I.A. Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove. Science 277 (1997) 339-345
69. Koch M., Stronge V.S., Shepherd D., Gadola S.D., Mathew B., Ritter G., et al. The crystal structure of human CD1d with and without alpha-galactosylceramide. Nat Immunol 6 (2005) 819-826
70. Jayawardena-Wolf J., Benlagha K., Chiu Y.H., Mehr R., and Bendelac A. CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 15 (2001) 897-908
71. Chen X., Wang X., Keaton J.M., Reddington F., Illarionov P.A., Besra G.S., et al. Distinct endosomal trafficking requirements for presentation of autoantigens and exogenous lipids by human CD1d molecules. J Immunol 178 (2007) 6181-6190
72. Kang S.J., and Cresswell P. Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules. EMBO J 21 (2002) 1650-1660
73. Lawton A.P., Prigozy T.I., Brossay L., Pei B., Khurana A., Martin D., et al. The mouse CD1d cytoplasmic tail mediates CD1d trafficking and antigen presentation by adaptor protein 3-dependent and -independent mechanisms. J Immunol 174 (2005) 3179-3186
74. Bendelac A., Savage P.B., and Teyton L. The biology of NKT cells. Annu Rev Immunol 25 (2007) 297-336
75. Kronenberg M. Toward an understanding of NKT cell biology: Progress and paradoxes. Annu Rev Immunol 23 (2005) 877-900
76. Van Kaer L. NKT cells: T lymphocytes with innate effector functions. Curr Opin Immunol 19 (2007) 354-364
77. Cerboni C., Achour A., Warnmark A., Mousavi-Jazi M., Sandalova T., Hsu M.L., et al. Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j. Eur J Immunol 36 (2006) 732-741